Hanja de Jager

Statistics

Publications

Citations

973

H-Index

Active since

2015

Affiliations

Leiden University Medical Center(Current)

Erasmus MC Cancer Institute

Radiotherapiegroep

Catharina Ziekenhuis

The Netherlands Cancer Institute

Hanja de Jager is an author at Leiden University Medical Center specializing in prostate cancer fractionation, radiation oncology, and prostate cancer.

Publications per year

2015–2016

Publications

Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial

Luca Incrocci, Ruud C. Wortel, Wendimagegn Alemayehu et al. · The Lancet Oncology · 2016 · 478 citations

Medicine, Radiation Oncology, Urology +14

Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial

Shafak Aluwini, Floris J. Pos, Erik C. Schimmel et al. · The Lancet Oncology · 2016 · 313 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial

Shafak Aluwini, Floris J. Pos, Erik C. Schimmel et al. · The Lancet Oncology · 2015 · 182 citations · Full text

Medicine, Oncology, Radiation Oncology +16

1–3 of 3